We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Solutions Company Expands Quality Control Offering

By LabMedica International staff writers
Posted on 29 Jun 2010
A new range of lyophilised quality controls ensures longer shelf life and stability, resulting in greater continuity of lot supply. More...
Other advantages of the new quality controls include more convenient storage at 2 °C - 8 °C and easier transportation.

The quality control sera are manufactured by Randox Laboratories (Crumlin, UK). Quality control guarantees good performance and ensures that results are of high quality and reliability. The company's Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls.

The new quality controls include coagulation, maternal screening, clinical chemistry, immunoassays, tumor markers, HbA1c, and thalassemia. Randox quality controls are true third party controls in that they are not designed or optimized for use with a specific manufacturer's instrument, calibrator, or reagent.

In addition to the extensive range of quality control materials Randox provides 24/7 an internet driven peer-group reporting system and RIQAS, an external quality assurance scheme providing customers with 15 external quality assessment (EQA) programs.

Randox develops, manufactures, and markets clinical diagnostic products including the Biochip Array Technology, clinical chemistry analyzers and reagents, quality controls, and EQA, as well as a complete life science range.

Related Links:
Randox Laboratories


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.